The first transformation of an existing Bulgarian capital company into a company with variable capital – a recently adopted by the legislator new form of company – is a already a fact. While the general expectations are that this new form of company is available for original incorporation and transformation is expected after these cease to be start-ups, it may be also appropriate for reshaping the business opportunities of already incorporated companies, eligible under the law. Our client Praeva Biotech, formerly wholly owned limited liability company, will continue to develop its business in the area of biotech innovations by making use of the advantages, provided for a company with variable capital. This project was completed primarily by Ina Raikova from Spasov & Bratanov.

 

Date: March 2025

Source: Spasov & Bratanov Lawyers’ Partnership 

 

More Posts

  Уважаеми клиенти, партньори и колеги, Уведомяваме Ви, че установихме опити за фишинг атаки чрез използване на публично известните от уеб-страницата ни име, лого и данни за контакт на адвокатско

Read More »

Spasov and Bratanov successfully advised the International Finance Corporation and Raiffeisenbank International AG Austria on one of the most significant financing transactions of the year in Bulgaria: a €90 million

Read More »

On 22 November 2024 the 11th edition of CEE Competition Law Day, organized by Marta Sendrowicz – partner with A&O Shearman – Poland, took place in Sofia, Bulgaria. CEE Competition

Read More »

This year Spasov & Bratanov made its annual Christmas donation in favor of the Bulgarian Natural Sciences Olympic Teams Association thus supporting the talented Bulgarian children in their path to

Read More »

Share: